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Summary Background: The incidence of chronic obstructive pulmonary disease
(COPD) is little investigated. This study assessed the incidence of a self-reported
physician’s diagnosis of chronic bronchitis and/or emphysema (CBE) and/or COPD
(CBE/COPD), and investigated the effects of a family history of CBE in 1992 and
change in smoking habits (assessed in 1992 and 2000) on this incidence.
Methods: A follow-up study in 2000 of 4933 subjects who responded to a
respiratory questionnaire study in 1992 was performed. Response rate was 86.8%.
Odds ratios (ORs) for incident cases of CBE/COPD were calculated by multiple
logistic regression.
Results: The cumulative incidence of a physician’s diagnosis of CBE/COPD was
2.9%. A family history of CBE predicted incident cases of CBE/COPD, OR 2.7 (95% CI
1.5–5.1). Also continuous smoking, relapse into smoking, or having stopped smoking
between 1992 and 2000 had elevated ORs for incident cases of CBE/COPD, 2.6 (1.4–
4.7), 7.2 (2.7–18.7), and 2.6 (1.3–5.3), while the OR for ex-smoking in 1992 as well
as 2000 was 0.9 (0.4–1.8).
Conclusions: A family history of CBE increases the risk for development of CBE/
COPD. Sustained smoking cessation over many years may be required to significantly
reduce the risk of developing CBE/COPD.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
A majority of studies on potential risk factors of
chronic obstructive pulmonary disease (COPD) have
been of a cross-sectional design. The Global Initia-
tive for Chronic Obstructive Lung Disease (GOLD)
states that more longitudinal studies are needed to
fully understand the epidemiology of the disease.1
There is a marked variability in the development
of COPD in response to cigarette smoking,2 but
severe alpha 1-antitrypsin deficiency remains the
only proven genetic risk factor for COPD.3,4 Cross-
sectional studies have found a great aggregation of
COPD in families.5–9 It would be of interest to
examine whether a family history of COPD is also
associated with the incidence of COPD.
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Positive effects of smoking cessation on lung
function both in smokers with and without COPD
are well documented,10–12 but the effects of
change in smoking habits over time on the
incidence of COPD seems to have been little
examined in a random population sample.
This study has assessed the incidence of a self-
reported physician’s diagnosis of chronic bronchitis
and/or emphysema (CBE) and/or COPD in subjects
who responded to a respiratory questionnaire. The
influence of a family history of CBE reported in 1992
and smoking habits reported in 1992 as well as 2000
on this incidence was examined.
Methods
Study area and population
The present study was performed in Sk(ane, the
southern-most county of Sweden. In 1992, the
study area included Malm .o, the third largest city in
Sweden, and all of its surrounding municipalities
with a mixture of densely populated and rural
regions.13 In 2000, the study area also comprised
Malm .o, but only half of its surrounding municipa-
lities.
In 1992, the questionnaire was sent to 12 071
subjects aged 20–59 years (70.1% response rate),
and in 2000–11 933 to subjects aged 18–77 years.
All subjects were randomly selected from the
Swedish Populations Register. A follow-up study
was performed in all subjects who in 1992 resided
in the present study area and still were residing
there (n ¼ 4790) or had moved to other parts of
Sk(ane or to some of its three neighbouring counties
(n ¼ 143). Since 1992, further 312 subjects had
moved elsewhere, were dead, or had unknown
addresses. The study was approved by the Medical
Ethics Committee, Lund University, Lund.
Questionnaire
The questionnaire in 2000, entitled; ‘‘Questions
about the Lungs’’, had the same layout as the one
used in 1992.8,13 That questionnaire was based on
the questionnaire used in the OLIN studies,14,15 and
other epidemiological studies, e.g. Stjernberg
et al.16 and Lindstrom et al.17 In turn, this
questionnaire was developed from a revised version
of the British Medical Research Council (BMRC)
questionnaire,18 with modifications from the Amer-
ican Thoracic Society19 and Tucson.20 The ques-
tionnaire in 2000 was complemented with specific
questions about COPD and a family history of COPD
(Appendix A). If no response was received within 2
weeks a first reminder was sent out, and finally,
after 10 weeks, a second, reminder including a new
questionnaire was mailed.
Prevalence and incidence of a physician’s
diagnosis of CBE/COPD
The prevalence of a physician’s diagnosis of CBE or
COPD was assessed from the questions: ‘‘Have you
been diagnosed by a doctor as having chronic
bronchitis and/or emphysema?’’, or COPD?’’ There
was no question on COPD in 1992.
The cumulative incidence of physician’s diagnosis
of CBE/COPD, was assessed from a positive answer
in 2000 regarding a physician’s diagnosis of CBE/
COPD, but negative answers in 1992 on the
questions on both self-reported CBE, and self-
reported physician’s diagnosis of CBE as well as a
negative answer on the question: ‘‘Do you usually
have cough with phlegm on most days during
periods of at least three months during at least
two successive years?’’, i.e. analogous to the
definition of chronic bronchitis.21
Smoking habits
Subjects with a positive answer to the question ‘‘Do
you smoke?’’ or: ‘‘Have you stopped smoking during
the last 12 months?’’ were classified as current
smokers. Subjects who had smoked but stopped
smoking more than a year ago were classified as ex-
smokers.
Social position
Statistics Sweden has elaborated a socio-economic
classification system.22 In its most aggregated form,
the classification of the economically active popu-
lation consists of six groups (Appendix B). Like in a
previous study,23 the economically active popula-
tion was further merged into the two groups ‘‘low
social position’’ and ‘‘middle/high social position’’.
Statistical analyses
The prevalence of a disease or a symptom was
calculated as percentage of positive answers to a
question. Non-responders to a single question were
quoted as having answered: ‘‘No/do not know’’.
Univariate logistic regression analysis was used to
test potential associations between separate fac-
tors reported in 1992 and the incidence of a
physician’s diagnosis of CBE/COPD between 1992
and 2000. Multiple logistic regression analysis
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(forward conditional) was used to assess the
simultaneous influence of conceivable factors on
the incidence of a self-reported physician’s diag-
nosis of CBE/COPD. The results are presented as
odds ratios (ORs) and 95% confidence intervals
(CIs). Factors for which the univariate logistic
regression analysis showed an association with the
incidence of a physician’s diagnosis of CBE/COPD
with a P value of o0.15 were included as
covariates in the multiple regression model. Age,
gender, and social position were controlled for in
this analysis. In addition, interaction terms be-
tween age, gender, a family history of CBE in 1992,
and smoking habits were tested in all different
combinations in the multiple regression analysis.
For smoking habits, a categorical variable, ‘‘change
in smoking habits’’, was created, categorized into
six categories based on smoking habits reported in
1992 and 2000, i.e: ex–ex (sustained quitting),
current–ex (stopped smoking), never–current
(started smoking), ex–current (relapse into smok-
ing), current–current (continuous smoking), and
never smoked. The latter category was reference.
The variable number of smoked cigarettes per day
was categorized into three categories with smoking
of o5 cigarettes/day as reference.
A non-response analysis in the follow-up study
group was performed by comparing basic demo-
graphics and answers to the questionnaire in 1992
between non-responders and responders. A similar
analysis was made in the 312 subjects not eligible
for the study in 2000. Chi-squared analysis was used
for comparison of prevalence rates between dif-
ferent groups. Differences by age were tested by
analysis of variance (ANOVA). A P-value of o0.05
was considered statistically significant. The com-
puter-based analysis-program SPSS version 10.1 was
used for all calculations.
Results
Participation
In 2000, in total 9316 individuals (78.1%) returned
the questionnaire. Of the 4933 subjects who
received the questionnaire in 1992 as well as in
2000 (the follow-up study group), 4280 subjects
(86.8%) responded at both occasions.
Prevalence of a physician’s diagnosis as well
as a family history of CBE (in 1992) and CBE/
COPD (in 2000)
A physician’s diagnosis of CBE/COPD was more
frequently reported in 2000 than a physician’s
diagnosis of CBE in 1992 (Po0:05) (Table 1). CBE
(in 1992) as well as CBE/COPD (in 2000) were more
common among women than men at both occa-
sions. Also, more women than men were smokers,
both in 1992 and 2000, Po0:05 and Po0:001;
respectively. The prevalence of smoking was
significantly lower in 2000 compared with 1992.
There was no statistical difference in report of a
family history of CBE between 1992 and 2000, but
significantly more women than men reported a
family history of CBE (Po0:001). In 1992, as well as
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Table 1 Prevalence (%) and 95% CIs of a self-reported physician’s diagnosis as well as a family history of CBE (in
1992), and CBE/COPD (in 2000), and of current and ex-smokers in 1992 and 2000 (n ¼ 4280).
1992 2000
All
(n ¼ 4280)
Men
(n ¼ 1972)
Women
(n ¼ 2308)
All
(n ¼ 4280)
Men
(n ¼ 1972)
Women
(n ¼ 2308)
Diagnosis of CBE
(in 2000 CBE/COPD)
3.7
3.2–4.2
3.3
2.6–4.1
4.1
3.3–4.9
4.3
3.8–4.9
3.8
2.9–4.6
4.7
3.8–5.5
Family history of CBE
(in 2000 CBE/COPD)
8.6
7.8–9.4
6.0
4.9–7.0
10.8
9.6–12.1
9.3
8.1–10.5
7.0
5.8–8.1
11.4
10.1–12.7
Current smokers 32.8
31.4–34.2
30.9
28.9–33.0
30.9
28.9–33.0
26.3
25.0–27.6
24.4
23.1–25.6
27.7
26.4–28.9
Ex-smokers 24.8
23.5–26.1
27.0
25.0–28.9
22.9
21.2–24.6
30.7
29.3–32.1
32.7
30.6–34.8
28.9
27.1–30.8
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in 2000, 33% of the subjects in the follow-up study
group were classified as having a ‘‘low social
position’’. Of subjects who in 2000 stated a
physician’s diagnosis of CBE, and COPD, respec-
tively, 79.7% and 92.5%, reported recurrent or
permanent breathing problems. Corresponding fig-
ures for symptoms of chronic bronchitis, i.e.
‘‘cough with phlegm during at least three months
during at least two successive years of the last
years’’ were 36.8% and 40.4%, respectively.
Incidence of a physician’s diagnosis of CBE/
COPD
The cumulative incidence of a physician’s diagnosis
of CBE/COPD in the follow-up study group was 2.9%
(48 males and 64 women). This corresponds to an
estimated annual incidence of 0.36%. Of these
subjects, 45% were current smokers and 36% were
ex-smokers. The highest numerical incidence of
CBE/COPD among women was noted in the age
group 48–57 years, while the highest numerical
incidence among men was found in oldest age group
(58–67 years) (Table 2). The incidence of a
physician’s diagnosis of CBE/COPD increased by an
increasing number of cigarettes smoked per day in
1992. For those who smoked 414 cigarettes/day,
the incidence was 6.6%.
Influence of a family history of CBE and
change in smoking habits
Results of the univariate logistic regression analyses
of potential associations between different factors
reported in 1992 and incident cases of a physician’s
diagnosis of CBE/COPD are shown in Table 3.
According to multiple logistic regression analysis
a family history of CBE in 1992 was a predictor of
incident cases of a self-reported physician’s diag-
nosis of CBE/COPD (Table 4). Also increase in age,
continuous smoking, relapse into smoking, and
stopped smoking between 1992 and 2000, were
associated with an elevated OR for the incidence of
CBE/COPD. For subjects who were ex-smokers both
in 1992 and 2000 (sustained quitters) the OR was
0.9 (0.4–1.8). Statistically, no significant interac-
tions were found between age, gender, smoking
habits, and report of a family history of CBE in
1992.
The prevalence of smoking was significantly
higher in subjects who reported a family history
of CBE or CBE/COPD than in the rest of the follow-
up group in 1992 as well as in 2000, 38.0% vs. 32.3%
and 31.8% vs. 25.8%, respectively. In addition,
smokers with a family history of CBE/COPD re-
ported a consumption of 414 cigarettes/day more
frequently than the rest of the smokers, 41.2% vs.
29.0%, in 2000.
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Table 2 Cumulative incidence rates (%) and 95% CIs of self-reported physician’s diagnosis of CBE/COPD between
1992 and 2000 by age (in 2000), and gender (n ¼ 4280).
Age group (age in 2000) (years) All (n ¼ 4280) Men (n ¼ 1972) Women (n ¼ 2308)
28–67 (All) 2.9 (2.4–3.4) 2.7 (1.9–3.4) 3.1 (2.3–3.8)
28–37 1.9 (1.0–2.7) 1.5 (0.3–2.6) 2.2 (0.9–3.4)
38–47 2.9 (1.8–4.0) 3.2 (1.5–4.8) 2.7 (1.2–4.1)
48–57 2.5 (1.5–3.5) 1.1 (0.1–2.0) 3.9 (2.2–5.6)
58–67 4.2 (3.0–5.5) 4.9 (2.9–6.9) 3.6 (2.0–5.2)
Table 3 Odds ratios and P-values according to univariate logistic regression analyses for incident cases of a
physician’s diagnosis of CBE/COPD between 1992 and 2000 of different factors reported in 1992.
n OR P-value
Being a man vs. woman 1972 0.9 0.266
Having a smoker in the home 658 0.9 0.423
Living close to heavy traffic 1426 1.3 0.056
Low social position vs. middle/high position 1411 1.5 0.055
A family history of CBE 368 2.8 o0.001
A family history of asthma 744 1.5 0.053
A family history of allergic rhinitis 1173 1.3 0.166
Being an ex-smoker vs. never smoker 1060 1.2 0.521
Being a current smoker vs. never smoker 1405 2.6 o0.001
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Non-response analysis
Of the 653 subjects who did not participate in 2000,
382 subjects were men and 271 were women. More
non-responders than responders were current
smokers in 1992, 41.5% vs. 32.8% (Po0:001). Non-
responders in 2000 had a higher prevalence of self-
reported symptoms of chronic bronchitis in 1992
than responders, 7.8% vs. 5.7% (P ¼ 0:025). There
were no differences between non-responders and
responders regarding the prevalence of ex-smo-
kers, a physician’s diagnosis of CBE, or a family
history of CBE in 1992.
No significant differences emerged between the
312 subjects, who were not eligible for the study in
2000 and the rest of the follow-up group regarding
age, gender, smoking habits and a physician’s
diagnosis of CBE in 1992.
Discussion
This study of a general population sample found an
estimated incidence of a self-reported physician’s
diagnosis of CBE/COPD of 0.36%. A family history of
CBE was an independent predictor of this inci-
dence. Continuous smoking as well as relapse into
smoking was associated with an elevated incidence
of CBE/COPD. This was also the case for having
stopped smoking between 1992 and 2000, while for
sustained ex-smokers (i.e. those who had quit
before 1992), the OR for incident cases of CBE/
COPD was similar to that for never smokers.
The found incidence of a physician’s diagnosis
CBE/COPD is of a similar order of magnitude as in a
few studies, which have evaluated the incidence of
COPD, both with spirometry. A Finnish study
performed between 1961 and 1971 found an annual
incidence of a ratio between forced expiratory
volume in 1 s (FEV1) and vital capacity (VC) ofo0.6
of 0.2%.24 A study from Poland found an incidence
of COPD, defined as FEV1o 65% of predicted, of
about 0.5%.25
A self-report of a physician’s diagnosis relies on
individual recall as well as on the accuracy of the
diagnosis. It would have been of interest to validate
the self-reported physician’s diagnosis of CBE/
COPD by performing spirometry, but this was not
feasible. The sensitivity of a physician’s diagnosis
of CBE/COPD is probably low, which is shown by
the considerable underdiagnosis of COPD,15 in
particular of mild-to-moderate COPD.1 However,
the specificity of a self-reported physician’s diag-
nosis of CBE/COPD may be relatively good and
useful for evaluation of risk associations in epide-
miological studies. This has been concluded in a
cohort study in nurses,26 but may need confirma-
tion also in a general population sample. In the
present study, a majority of subjects with a
physician’s diagnosis of CBE or COPD reported
problems with their breathing, which is character-
istic for COPD. Also the fact that the incidence of a
physician’s diagnosis of CBE/COPD was associated
with increase in age, smoking, and high cigarette
consumption supports the specificity of a self-
reported physician’s diagnosis of CBE/COPD. We
also believe that a predominant part of the
subjects who reported a physician’s diagnosis of
CBE/COPD indeed had a clinically significant
disease, i.e. of sufficient severity to prompt a visit
to a physician. This thought is in accordance with
GOLD.1 COPD may sometimes be confused with
asthma, but there are in fact some individuals
with both diseases. It is unknown how great
this percentage is. In the present study, about
19% of the subjects with CBE/COPD reported a
concomitant asthma.
One may speculate whether the incidence rate
found in the study may be overestimated due to an
increasing focus on COPD in recent years. However,
this may be counterbalanced by fact that the
prevalence of current smokers in 1992 was greater
among non-responders than responders, which thus
may instead have led to an underestimation of the
incidence.
The present results support that a family history
of COPD is an important risk factor for the
ARTICLE IN PRESS
Table 4 ORs and 95% CIs for incident cases of self-
reported physician’s diagnosis of CBE/COPD be-
tween 1992 and 2000 according to stepwise multi-
ple logistic regression (forward conditional)
controlling for age, gender and smoking.
n OR 95% CI
A family history
of CBE in 1992
368 2.7 1.5–5.1
Never smoked
(reference)
1785 1.0
Stopped smoking 448 2.6 1.3–5.3
Relapse into
smoking
85 7.2 2.7–18.7
Continuous
smoking
957 2.6 1.4–4.7
Smoking of
414 cigarettes/
day in 1992
560 4.0 1.1–14.9
A family history of asthma and living close to heavy
traffic, were included as covariates in the model, but due
to a final P-value of40.05 their results are not displayed.
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development of COPD. However, it still remains to
be clarified to what extent a family history of COPD
really reflects genetic risk factors. A questionnaire
cannot cover all conceivable questions on environ-
mental risk factors, and in addition, it cannot
adequately measure the degree of different ex-
posures. Furthermore, recognised risk factors such
as childhood infections,3 poor socio-economic
status,27 and environmental tobacco smoke in the
family28 may have had an effect before the first
questionnaire study, and could then have led to an
increased familial risk of CBE/COPD. Also, having a
family member with CBE or COPD may lead to
an increased knowledge of these conditions and
to an increased awareness when known disease
symptoms occur, which might have resulted in
a bias.
Subjects with a family history seemed to have
somewhat more ‘‘heavy’’ smoking habits than
the rest of the study population which su-
ggests that smokers with a family history of CBE/
COPD is a particular target group for smoking
cessation.
Subjects who had stopped smoking between 1992
and 2000 had an OR for the incidence of a
physician’s diagnosis of CBE/COPD similar to
that for continuous smokers. This might to some
extent be explained by the fact that subjects
who received a diagnosis of CBE/COPD may have
been more motivated to stop smoking, i.e. were
more frequently ex-smokers in 2000. However,
those who reported that they were ex-smokers at
both occasions (sustained quitters) had an OR
similar to that of never smokers. This seems to
indicate that a successful smoking cessation in a
random sample of smokers can lead to a substantial
reduction in the risk of developing a clinically
significant COPD, but that it may take several years
until the full effect is achieved. The beneficial
long-term effect of smoking cessation is also shown
by the American Lung Health Study.12 Of smokers
who quit in the beginning of the study, only 10% had
an FEV1 of less than 60% of predicted after 11 years,
while this occurred in 38% of the continuous
smokers.
Relapse into smoking appeared to be asso-
ciated with a somewhat higher incidence of
CBE/COPD than continuous smoking. The former
group was, however, relatively small and this
result should therefore be interpreted with
caution. The finding is line with the a study
from Tucson,29 where subjects who attempted
to quit smoking but started again had a more
rapidly declining FEV1 than continuously smoking
and ex-smoking subjects. However, in the American
Lung Health Study, subjects who made several
attempts to quit smoking had less loss of lung
function.30
Conclusion
In conclusion, the estimated incidence of a physi-
cian’s diagnosis of CBE/COPD, which may represent
a clinically significant COPD was 0.36% in a random
population sample. A family history of CBE is an
independent predictor for the development of
CBE/COPD. A successful smoking cessation over
many years may be required to achieve a significant
reduction in the risk of developing CBE/COPD.
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Appendix A
Questionnaire (‘‘Questions about the
Lungs’’ in 1992)
Answer by crossing on the relevant line if no other
instructions are given.
1. Have any of your parents, brothers or sisters,
or children had:
a) Asthma.
b) Allergic eye-/nose catarrh (hay-fever)
c) Chronic bronchitis and/or emphysema
2. Have you now, or have you had, any of the
following diseases:
a) Asthma
b) Allergic eye/nose catarrh (hay-fever
c) Chronic bronchitis and/or emphysema
d) Any other lung or airways disease
e) If yes, which?yyyyyyyy..)
4. Have you been diagnosed by a doctor as having
chronic bronchitis (bronchitis) and/or
emphysema?
8. Do you usually have phlegm when coughing, or
do you have phlegm on your chest which is
difficult to bring up?
If yes:
a Do you bring up phlegm when coughing on
most days during periods of at least three
months?
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b Have you had such periods during at least
two successive years?
12. How would you characterise your breathing?
a) I very seldom have problems with my
breathing.
b) Occasionally I have problems when
breathing
c) My breathing is never quite well.
13 Do you smoke? (smokers also include those
who smoke a few cigarettes or pipe fills a
week, and those who have stopped smoking
during the last year)
If yes:
How many cigarettes do you smoke per day?
a) Less than 5
b) 5–14
c) 15 or more
If no:
d) Have you been a smoker but stopped
smoking more than a year ago?
e) Does anyone else in your family smoke?
14 Do you live close to a road with heavy traffic?
Questionnaire (‘‘Questions about the
Lungs’’ in 2000)
Answer by crossing on the relevant line if no other
instructions are given.
1.. Have any of your parents, brothers or sisters,
or children had:
a) Asthma
b) Allergic eye-/nose catarrh (hay-fever)
c) Chronic bronchitis and/or emphysema
d) Chronic obstructive pulmonary disease
(COPD)
3. Have you now, or have you had, any of the
following diseases:
a) Asthma
b) Allergic eye/nose catarrh (hay-fever)
c) Chronic bronchitis and/or emphysema
d) Chronic obstructive pulmonary disease
(COPD)
e) Any other lung or airways disease
f) If yes, which?yyyyyyyy)
5. Have you been diagnosed by a doctor as having
chronic bronchitis (bronchitis) and/or
emphysema?
6. Have you been diagnosed by a doctor as having
chronic obstructive pulmonary disease
(COPD)?
11. Do you usually have phlegm when coughing, or
do you have phlegm on your chest which is
difficult to bring up?
If yes:
a) Do you bring up phlegm when coughing on
most days during periods of at least three
months?
b) Have you had such periods during at least
two successive years?
15. How would you characterise your breathing?
Answer with a cross at the relevant line
a) I very seldom have problems with my
breathing.
b) Occasionally I have problems when
breathing.
c) My breathing is never quite well.
16. Do you smoke? (smokers also include those
who smoke a few cigarettes or pipe fills a
week, and those who have stopped smoking
during the last year)
If yes:
How many cigarettes do you smoke per day?
a) Less than 5
b) 5–14
c) 15 or more
If no:
d) Have you been a smoker but stopped
smoking more than a year ago?
e) Does anyone else in your family smoke?
17. Do you live close to a road with heavy traffic?
Appendix B
Statistics Sweden has elaborated a socio-economic
classification system (22). In its most aggregated
form the classification of the economically active
population consists of six groups:
1. Unskilled and semiskilled workers.
2. Skilled workers.
3. Assistant non-manual employees.
4. Intermediate non-manual employees.
5. Employed and self-employed professionals,
higher civil servants and executives.
6. Self-employed (other than professionals).
In our analyses the economically active popula-
tion was further merged into the two groups ‘‘low
social position’’ and ‘‘middle/high social position’’,
where low social position was defined by groups 1
and 2, whereas middle/high social position was
defined by groups 3–6.
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